title: Calcitonin gene-related peptide receptors in rat trigeminal ganglion do not control spinal trigeminal activity.
abstract: Calcitonin gene-related peptide (CGRP) is regarded as a key mediator in the generation of primary headaches. CGRP receptor antagonists reduce migraine pain in clinical trials and spinal trigeminal activity in animal experiments. The site of CGRP receptor inhibition causing these effects is debated. Activation and inhibition of CGRP receptors in the trigeminal ganglion may influence the activity of trigeminal afferents and hence of spinal trigeminal neurons. In anesthetized rats extracellular activity was recorded from neurons with meningeal afferent input in the spinal trigeminal nucleus caudalis. Mechanical stimuli were applied at regular intervals to receptive fields located in the exposed cranial dura mater. α-CGRP (10(-5) M), the CGRP receptor antagonist olcegepant (10(-3) M), or vehicle was injected through the infraorbital canal into the trigeminal ganglion. The injection of volumes caused transient discharges, but vehicle, CGRP, or olcegepant injection was not followed by significant changes in ongoing or mechanically evoked activity. In animals pretreated intravenously with the nitric oxide donor glyceryl trinitrate (GTN, 250 μg/kg) the mechanically evoked activity decreased after injection of CGRP and increased after injection of olcegepant. In conclusion, the activity of spinal trigeminal neurons with meningeal afferent input is normally not controlled by CGRP receptor activation or inhibition in the trigeminal ganglion. CGRP receptors in the trigeminal ganglion may influence neuronal activity evoked by mechanical stimulation of meningeal afferents only after pretreatment with GTN. Since it has previously been shown that olcegepant applied to the cranial dura mater is ineffective, trigeminal activity driven by meningeal afferent input is more likely to be controlled by CGRP receptors located centrally to the trigeminal ganglion.
authors.affiliation: Institute of Physiology and Pathophysiology, University of Erlangen-Nürnberg, Erlangen, Germany.
authors.forename: Oana
authors.initials: O
authors.lastname: Covasala
authors.forename: Sören L
authors.initials: SL
authors.lastname: Stirn
authors.forename: Stephanie
authors.initials: S
authors.lastname: Albrecht
authors.forename: Roberto
authors.initials: R
authors.lastname: De Col
authors.forename: Karl
authors.initials: K
authors.lastname: Messlinger
mesh_terms: D000200:Action Potentials / Q000502:physiology*; D000818:Animals; D008297:Male; D009474:Neurons / Q000502:physiology*; D020671:Posterior Horn Cells / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D018015:Receptors, Calcitonin Gene-Related Peptide / Q000378:metabolism*; D012668:Trigeminal Ganglion / Q000502:physiology*
chemical_list: D018015:Receptors, Calcitonin Gene-Related Peptide